Skip to main content
. Author manuscript; available in PMC: 2013 Jun 20.
Published in final edited form as: Doc Ophthalmol. 2010 Sep 15;121(3):231–240. doi: 10.1007/s10633-010-9247-9

Fig. 3.

Fig. 3

Spectral-domain OCT scans demonstrate the reduction of the macular cysts and retinal thickness while on treatment with topical dorzolamide 2% in the left (treated) eye (A and B) following two months of treatment. Also, SD-OCT scans showed that retinal thickness in the right (untreated) eye remained essentially constant.